) 9 0 6) The main Revenue f For the six increasing year. The i parent com increased b 83.51 milli For the sec main reaso same perio sales incre by Baht 55 Cost of sal For the six reason was same perio

. Q2’ 2019 Q2’ 2018 Increase (decrease) Million Baht % Million Baht % Million Baht % Revenues from main business EMS business 387 22% 389 21% (2) (1%) Enterprise solution business 419 24% 471 26% (52

% Million Baht % Million Baht % Revenues from main business EMS business 476 24% 524 33% (48) (9%) Telecommunication business 396 20% 58 4% 338 583% Related technology business 166 9% 191 12% (25) (13

gross main income of the Company and subsidiary companies in Q3/2018 was 2,290.65 million THB, decreasing 55.83 million THB from Q3/2017 or 2.38% only. But the gross profit from sales has increased 6.82

, production of 10.4 MMt, core EBITDA of $1.4 billion and core ROCE of 13.7%. It is important to remind our stakeholders that this performance has been achieved despite headwinds in the main integrated aromatics

and the three-month period ended March 31, 2018, respectively. The figures represent a period-on-period increase of 14.90% due mainly to an increasing in number of patients and adjustment of prices in

31 December 2017, respectively. The figures represent a year-on-year increase of 0.79%. Cost of hospital operations The cost of hospital operations amounted to Baht 273.54 million and Baht 282.81

represent entitlement in assets held by a derivatives broker for its client for delivery settlement according to client’s derivatives transaction; (d) cash, securities, or any other assets which a derivatives

positions held by a client; (b) profit or any other interests resulted from derivatives transaction of a client; (c) warehouse receipt, bill of lading, or any other instruments which represent entitlement in

client; (b) profit or any other interests resulted from derivatives transaction of a client; (c) warehouse receipt, bill of lading, or any other instruments which represent entitlement in assets held by a